Correlation Between Nuvectis Pharma and Ventyx Biosciences
Can any of the company-specific risk be diversified away by investing in both Nuvectis Pharma and Ventyx Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvectis Pharma and Ventyx Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nuvectis Pharma and Ventyx Biosciences, you can compare the effects of market volatilities on Nuvectis Pharma and Ventyx Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvectis Pharma with a short position of Ventyx Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvectis Pharma and Ventyx Biosciences.
Diversification Opportunities for Nuvectis Pharma and Ventyx Biosciences
0.29 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Nuvectis and Ventyx is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Nuvectis Pharma and Ventyx Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ventyx Biosciences and Nuvectis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvectis Pharma are associated (or correlated) with Ventyx Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ventyx Biosciences has no effect on the direction of Nuvectis Pharma i.e., Nuvectis Pharma and Ventyx Biosciences go up and down completely randomly.
Pair Corralation between Nuvectis Pharma and Ventyx Biosciences
Given the investment horizon of 90 days Nuvectis Pharma is expected to generate 0.69 times more return on investment than Ventyx Biosciences. However, Nuvectis Pharma is 1.45 times less risky than Ventyx Biosciences. It trades about -0.03 of its potential returns per unit of risk. Ventyx Biosciences is currently generating about -0.04 per unit of risk. If you would invest 1,580 in Nuvectis Pharma on August 28, 2024 and sell it today you would lose (1,085) from holding Nuvectis Pharma or give up 68.67% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Nuvectis Pharma vs. Ventyx Biosciences
Performance |
Timeline |
Nuvectis Pharma |
Ventyx Biosciences |
Nuvectis Pharma and Ventyx Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Nuvectis Pharma and Ventyx Biosciences
The main advantage of trading using opposite Nuvectis Pharma and Ventyx Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvectis Pharma position performs unexpectedly, Ventyx Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ventyx Biosciences will offset losses from the drop in Ventyx Biosciences' long position.Nuvectis Pharma vs. Replimune Group | Nuvectis Pharma vs. Lyra Therapeutics | Nuvectis Pharma vs. Kronos Bio | Nuvectis Pharma vs. Gossamer Bio |
Ventyx Biosciences vs. Arcellx | Ventyx Biosciences vs. Immunocore Holdings | Ventyx Biosciences vs. Vaxcyte | Ventyx Biosciences vs. Nuvalent |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Fundamental Analysis View fundamental data based on most recent published financial statements |